These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8296317)

  • 1. Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity.
    Guengerich FP
    Toxicol Lett; 1994 Feb; 70(2):133-8. PubMed ID: 8296317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human cytochrome P450 enzymes.
    Guengerich FP
    FASEB J; 1992 Jan; 6(2):745-8. PubMed ID: 1537465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450s and other enzymes in drug metabolism and toxicity.
    Guengerich FP
    AAPS J; 2006 Mar; 8(1):E101-11. PubMed ID: 16584116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
    Yamazaki H
    Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.
    Forrester LM; Henderson CJ; Glancey MJ; Back DJ; Park BK; Ball SE; Kitteringham NR; McLaren AW; Miles JS; Skett P
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):359-68. PubMed ID: 1736885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.
    Guengerich FP
    Chem Res Toxicol; 2017 Jan; 30(1):2-12. PubMed ID: 27472660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro techniques for studying drug metabolism.
    Guengerich FP
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):521-33. PubMed ID: 9131489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism.
    Lewis DF
    Biochem Pharmacol; 2000 Aug; 60(3):293-306. PubMed ID: 10856424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational prediction of drug binding and rationalisation of selectivity towards cytochromes P450.
    Stjernschantz E; Vermeulen NP; Oostenbrink C
    Expert Opin Drug Metab Toxicol; 2008 May; 4(5):513-27. PubMed ID: 18484912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome p450 part 2: what nurses need to know about the cytochrome p450 family systems.
    Krau SD
    Nurs Clin North Am; 2013 Dec; 48(4):681-96. PubMed ID: 24295195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Structural Insights into Cytochrome P450 Function.
    Guengerich FP; Waterman MR; Egli M
    Trends Pharmacol Sci; 2016 Aug; 37(8):625-640. PubMed ID: 27267697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytochrome P450 isoenzymes in metabolism of endo- and exogenic compounds].
    Wiśniewska A; Mazerska Z
    Postepy Biochem; 2009; 55(3):259-71. PubMed ID: 19928582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic assays for human cytochrome P450: an introduction.
    Chang TK; Waxman DJ
    Methods Mol Biol; 2006; 320():73-83. PubMed ID: 16719375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochromes P450 in the bioactivation of chemicals.
    Ioannides C; Lewis DF
    Curr Top Med Chem; 2004; 4(16):1767-88. PubMed ID: 15579107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF; Jacobs MN; Dickins M
    Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 inactivation by pharmaceuticals and phytochemicals: therapeutic relevance.
    Johnson WW
    Drug Metab Rev; 2008; 40(1):101-47. PubMed ID: 18259986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome p450 part 3: drug interactions: essential concepts and considerations.
    Krau SD
    Nurs Clin North Am; 2013 Dec; 48(4):697-706. PubMed ID: 24295196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple activated oxygen species in P450 catalysis: contributions To specificity in drug metabolism.
    Coon MJ; Vaz AD; McGinnity DF; Peng HM
    Drug Metab Dispos; 1998 Dec; 26(12):1190-3. PubMed ID: 9860926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity.
    Nelson SD; Trager WF
    Drug Metab Dispos; 2003 Dec; 31(12):1481-98. PubMed ID: 14625345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.